City
Epaper

Individual's immune response to Covid virus may determine vax efficacy

By IANS | Updated: November 13, 2023 18:45 IST

Tokyo, Nov 13 Researchers have found that individual immune responses to the SARS-CoV-2 virus, particularly in mutant strains, ...

Open in App

Tokyo, Nov 13 Researchers have found that individual immune responses to the SARS-CoV-2 virus, particularly in mutant strains, can influence the efficacy of Covid-19 vaccines.

Efforts to contain the Covid-19 pandemic have largely focused on vaccine development and deployment.

But how exactly do our immune systems respond to Covid-19 vaccines?

The major response occurs in one of two ways: the production of antibodies that bind to the receptor-binding domain (RBD) or the production of antibodies that bind to the N-terminal domain (NTD) of the coronavirus viral spike protein.

Both play important roles in preventing infection, pathogenesis, and severe disease.

However, the antibody repertoire varies widely among individuals.

While it has been suggested that this diversity in antibodies influences the ability to protect against mutant strains, its full extent has not been clear.

A team led by Osaka Metropolitan University researchers gained insight into the role of antibodies produced by vaccination in preventing infections, particularly in mutant strains of the coronavirus.

"The results of this study have demonstrated that understanding the nuances of antibody response to vaccination is critical for vaccine development," said Mayo Yasugi, an Associate Professor at the Graduate School of Veterinary Science at Osaka.

"We believe our findings will provide a foundation for improved vaccine development in the future," Yasugi added. The study, published in the journal Vaccine, focused on blood samples taken from volunteers 17 to 28 days post-2nd vaccination, a crucial period when antibody production peaks.

Furthermore, the study found that antibodies that primarily target NTD have a lower ability to protect against a delta variant of the coronavirus compared to those primarily targeting RBD.

Interestingly, the study also found that the presence or absence of infectivity-enhancing antibodies did not affect the ability of the antibodies to protect against variants.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalMaoist plot foiled in Odisha: Explosives cache unearthed in Kandhamal forest sweep

NationalRajasthan CM's gift for state's youth: Recruitment to be made for 26,000 posts

NationalGujarat: Sabar Dairy announces revised milk price for cattle farmers amid protests

NationalUP Shocker: Boy Drowns in River While Making Reel in Prayagraj, Bystanders Record Instead of Rescuing

NationalMadhya Pradesh govt plans to start 68 new kitchens under Deendayal Rasoi Yojana

International Realted Stories

InternationalMos Pabitra Margherita engages in bilateral talks with Eswatini leaders

InternationalMinister Sa'ar orders emergency aid to Druze in Sweida

InternationalNagaland showcases economic, cultural potential at 'Bharat Utsav 2025' in Moscow: Officials

InternationalFive rockets intercepted over past week amid ongoing fire from Gaza

InternationalIsraeli soldier arrested for passing missile footage to Iran